HoomanYonatanSazegarDO

PubMed

• 14 citations
  Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab
  F. Javier Ibarrondo, Otto O. Yang, Thinle Chodon, Earl Avramis, Yohan Lee, Hooman Sazegar, Jason Jalil, Bartosz Chmielowski, Richard C. Koya, Ingrid Schmid, Jesus Gome...> ;Plos One. 2013 Oct 22
• 120 citations
  CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans
  Rong Rong Huang, Jason Jalil, James S. Economou, Bartosz Chmielowski, Richard C. Koya, Stephen Mok, Hooman Sazegar, Elizabeth Seja, Arturo Villanueva, Jesus Gomez-Nava...> ;Clinical Cancer Research. 2011 Jun 15
• 70 citations
  Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
  Franziska Niehr, Erika von Euw, Narsis Attar, Deliang Guo, Doug Matsunaga, Hooman Sazegar, Charles Ng, John A. Glaspy, Juan A. Recio, Roger S. Lo, Paul S. Mischel, Beg...> ;Journal of Translational Medicine. 2011 May 24
• 1667 citations
  Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
  Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C. Koya, Hane Lee, Zugen Chen, Mi Kyung Lee, Narsis Attar, Hooman Sazegar, Thinle Chodon, Stanley F. Nelson,...> ;Nature. 2010 Dec 16
• 120 citations
  The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
  Begoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, Douglas Matsunaga, Stephen Mock, Jason Jalil, Helena Escuin-Ordinas, Bartosz Chmielowski, Richard C. Koya, Antoni R...> ;Clinical Cancer Research. 2010 Dec 15
• 23 citations
  Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma
  Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, Douglas Matsunaga, Jason Jalil, Erika von Euw, Helena Escuin-Ordinas, Robert Balderas, Bartosz Chmielowski, Jesus G...> ;Plos One. 2010 Sep 15
• 182 citations
  Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
  Jonas Nørskov Søndergaard, Ramin Nazarian, Qi Wang, Deliang Guo, Teli Hsueh, Stephen Mok, Hooman Sazegar, Laura E. MacConaill, Jordi Barretina, Sarah M. Kehoe, Narsis ...> ;Journal of Translational Medicine. 2010 Apr 20
• Join now to see all